Aduro Clean Technologies (ACT) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
22 Sep, 2025Executive summary
Advanced construction of the NGP Pilot Plant, with commissioning set for September 2025, and expanded feedstock testing, including synthetic turf, drawing industry interest.
Deepened customer engagement and industry presence through new partnerships and association memberships, positioning for technology scalability.
Maintained financial discipline while investing in scale-up, supported by a strong balance sheet and successful equity financing.
Financial highlights
Q4 2025 revenue was $74,670, down 27% from Q4 2024; annual revenue for FY2025 was $231,212, a 31% decrease year-over-year.
Loss from operations increased to $3.72 million in Q4 2025 (from $1.79 million in Q4 2024) and $12.15 million for FY2025 (up 63% from FY2024).
Cash position at year-end was $6.96 million, up 147% from $2.81 million in 2024, bolstered by a US$9.2 million public offering post-year-end.
Property, plant, and equipment rose to $5.1 million, reflecting investment in research and pilot plant construction.
Outlook and guidance
Commissioning of the NGP Pilot Plant is scheduled to begin in September 2025, with phased integration and initial operating campaigns to follow.
Additional resources from recent financing will support ongoing R&D and commercialization efforts.
Latest events from Aduro Clean Technologies
- Innovative recycling tech enables low-cost, scalable plastic waste conversion, with strong industry traction.ACT
LD Micro Main Event XIX Investor Conference3 Feb 2026 - Q2 2026 delivered strong revenue growth and capital raise, advancing scale-up and demonstration plans.ACT
Q2 202615 Jan 2026 - Innovative recycling platform targets landfill plastics with scalable, flexible business models.ACT
H.C. Wainwright 27th Annual Global Investment Conference31 Dec 2025 - Pilot plant commissioning advanced, cash reserves grew, but revenue fell and losses widened.ACT
Q1 202630 Dec 2025 - Revenue surged 208% year-over-year as technology and global partnerships advanced.ACT
Q4 20241 Jul 2025 - Advanced R&D, new patent, and strong cash position support technology scale-up and growth.ACT
Q1 20251 Jul 2025 - Nasdaq uplisting, new funding, and pilot plant advances drive commercialization amid revenue decline.ACT
Q2 20251 Jul 2025 - Q3 2025 saw lower revenue and higher losses, but key milestones and strong cash support growth.ACT
Q3 20251 Jul 2025